A novel nasal powder formulation of glucagon: toxicology studies in animal models

BACKGROUND: Glucagon nasal powder (GNP), a novel intranasal formulation of glucagon being developed to treat insulin-induced severe hypoglycemia, contains synthetic glucagon (10 % w/w), beta-cyclodextrin, and dodecylphosphocholine. The safety of this formulation was evaluated in four studies in anim...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:BMC Pharmacol Toxicol
मुख्य लेखकों: Reno, Frederick E., Normand, Patrick, McInally, Kevin, Silo, Sherwin, Stotland, Patricia, Triest, Myriam, Carballo, Dolores, Piché, Claude
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2015
विषय:
Research Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4621930/
https://ncbi.nlm.nih.gov/pubmed/26502880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-015-0026-9
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन